GSK plc. (1/13/25). "Press Release: GSK Enters Agreement to Acquire IDRx, Inc.". London. |
2025-01-13 |
bioMérieux S.A.. (1/13/25). "Press Release: bioMérieux to Present at the 43rd Annual J.P. Morgan HealthCare Conference". Marcy l’Étoile. |
2025-01-13 |
bioMérieux S.A.. (1/13/25). "Press Release: bioMérieux Strengthens Its Point of Care Presence with the Acquisition of the immunoassay Start-up SpinChip". Marcy l’Étoile. |
2025-01-13 |
Windward Bio AG. (1/10/25). "Press Release: Windward Bio Launches With $200 Million Series A Financing to Develop Phase 2-Ready, Long-Acting Anti-TSLP Antibody With Best-in-Class Potential in Asthma and COPD". Basel. |
2025-01-10 |
Graph Therapeutics FlexCo. (1/9/25). "Press Release: Graph Therapeutics Raises $3.1M Pre-Seed Round to Transform Drug Discovery for Immunological Diseases". Vienna. |
2025-01-09 |
Coave Therapeutics (Horama S.A.). (1/9/25). "Press Release: Coave Therapeutics Secures €32 Million ($33 Million) in Series A Financing to Advance its Next-Generation Genetic Medicines". Paris. |
2025-01-09 |
Numab Therapeutics AG. (1/9/25). "Press Release: Numab Therapeutics Announces Series C Extension to CHF 180 Million, Completing Oversubscribed CHF 50 Million Financing". Horgen. |
2025-01-09 |
Alesta Therapeutics B.V.. (1/8/25). "Press Release: Alesta Therapeutics Raises €65 Million Series A Financing to Advance Oral Small Molecules for Rare Diseases". Leiden. |
2025-01-08 |
Argobio SAS. (1/7/25). "Press Release: Next-generation RNA Company Inverna Therapeutics Launched by Argobio and University of Southern Denmark". Odense. |
2025-01-07 |
Senseera Ltd.. (1/7/25). "Press Release: Senseera Raises $7.1 Million Seed Round Led by Lightspeed Venture Partners". Jerusalem. |
2025-01-07 |
Orbis Medicines ApS. (1/6/25). "Press Release: Orbis Medicines Raises EUR 90 Million Series A Funding Round to Develop Pipeline of Oral Macrocycles". Copenhagen. |
2025-01-06 |
XGen Venture SGR S.p.A.. (12/19/24). "Press Release: XGen Venture Announces Final Closing of €180M ($190M) Life Sciences Fund". Milan. |
2024-12-19 |
Ottimo Pharma Ltd.. (12/19/24). "Press Release: Ottimo Pharma Raises over $140 Million in Series A Financing". London & Boston, MA. |
2024-12-19 |
Merck KGaA. (12/17/24). "Press Release: Merck to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio". Darmstadt. |
2024-12-17 |
Gilde Healthcare Partners. (12/16/24). "Press Release: Gilde Healthcare Invests alongside Capital A in Tromp Medical to Accelerate International Growth in the Medical Imaging Market". Utrecht. |
2024-12-16 |
Mainz Biomed N.V.. (12/16/24). "Press Release: Mainz Biomed Announces Closing of $8.0 Million Follow-On Offering". Berkeley, CA & Mainz. |
2024-12-16 |
Single Use Support GmbH. (12/16/24). "Press Release: Darren Verlenden New CEO of Single Use Support". Kufstein. |
2024-12-16 |
Pharming Group N.V.. (12/15/24). "Press Release: Pharming Announces Public Cash Offer to the Shareholders of Abliva AB". Leiden. |
2024-12-15 |
Palvella Therapeutics, Inc.. (12/13/24). "Press Release: Palvella Therapeutics Announces Closing of Merger with Pieris Pharmaceuticals and Concurrent Private Placement of $78.9 Million". Wayne, PA. |
2024-12-13 |
Andera Partners. (12/12/24). "Press Release: New York Life Investments and Its European Affiliate, Candriam, Announce Strategic Partnership with Andera Partners". New York, NY, Paris & Brussels. |
2024-12-12 |
EQT AB. (12/11/24). "Press Release: EQT Life Sciences Leads Series B Extension in Noema Pharma, Raising Total Series B Financing to CHF 130 million". |
2024-12-11 |
Syncell, Inc.. (12/11/24). "Press Release: Syncell Announces $ 15 Million Series A Funding To Accelerate The Global Commercial Growth Of ITS Protein Purification And Spatial Proteomics Technology". Taipei & Watertown, MA. |
2024-12-11 |
Aqemia SAS. (12/10/24). "Press Release: Aqemia Hits $100 Million Funding Milestone, Paving Way to Clinical Trials and Global Expansion Starting with London, UK". Paris & London. |
2024-12-10 |
Relation Therapeutics Ltd.. (12/10/24). "Press Release: Relation Announces Two Strategic Collaborations with GSK to Advance Therapeutics for Fibrotic Diseases and Osteoarthritis". London. |
2024-12-10 |
Citryll B.V.. (12/9/24). "Press Release: Citryll Raises EUR 85 Million Series B to Advance Novel NET-Targeting Therapy for Immune-Mediated Inflammatory Disorders". Oss. |
2024-12-09 |
Newcells Biotech Ltd.. (12/5/24). "Press Release: Newcells Biotech Raises Additional Funding from Investors". Newcastle. |
2024-12-05 |
miDiagnostics N.V.. (12/4/24). "Press Release: miDiagnostics Secures €30 Million Series D Funding Round Led by Thermo Fisher Scientific to Advance an Innovative Sterility Test and Other Quality Control Tests for use in the BioPharma Industry". Leuven. |
2024-12-04 |
Abselion (HexagonFab Ltd.). (12/4/24). "Press Release: Abselion Raises £6.6 Million Led by M Ventures to Bring Disruptive At-line Protein Analyser, Amperia, to Market". Cambridge. |
2024-12-04 |
Antag Therapeutics. (12/4/24). "Press Release: Antag Therapeutics Announces €80 Million Series A Financing". Copenhagen. |
2024-12-04 |
ViveBiotech S.L.. (12/4/24). "Press Release: ViveBiotech Secures Growth Investment from Ampersand Capital Partners to Expand Lentiviral Vector Development and Manufacturing Capabilities". |
2024-12-04 |
H. Lundbeck A/S. (11/18/24). "Press Release: Lundbeck Announces Expiration of Longboard Tender Offer and That All Tender Offer Conditions Are Fulfilled". |
2024-11-28 |
Kyan Health AG. (11/26/24). "Press Release: Kyan Health Raises $16.7m to Upgrade Workplace Wellness with AI-powered Preventative Care". |
2024-11-26 |
Roche. (11/26/24). "Press Release: Roche Enters into a Definitive Agreement to Acquire Poseida Therapeutics, Including Cell Therapy Candidates and Related Platform technologies". Basel. |
2024-11-26 |
Adcendo ApS. (11/25/24). "Press Release: Adcendo ApS Completes Oversubscribed $135 Million Series B Financing to Advance First-in-class ADC Pipeline". Copenhagen. |
2024-11-25 |
Adragos Pharma GmbH. (11/25/24). "Press Release: Adragos Pharma Acquires Baccinex – a Leading Swiss Sterile Fill-Finish Expert". Munich & Courroux. |
2024-11-25 |
Halozyme Therapeutics, Inc.. (11/22/24). "Press Release: Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions". San Diego, CA. |
2024-11-22 |
Versant Ventures. (11/21/24). "Press Release: Versant Ventures Unveils Pep2Tango Therapeutics Inc.". Potomac, MD. |
2024-11-21 |
Bico Group AB. (11/21/24). "Press Release: Bico Has Entered into an Agreement to Divest Nanoscribe". |
2024-11-21 |
Novartis AG. (11/21/24). "Press Release: Addressing Unmet Needs for Inherited Neuromuscular Diseases. Novartis Has Acquired Kate Therapeutics to Further Enhance and Strengthen Our Ongoing Efforts to Advance Gene Therapies for Patients". |
2024-11-21 |
Halozyme Therapeutics, Inc.. (11/18/24). "Press Release: Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec". San Diego, CA. |
2024-11-18 |
Halozyme Therapeutics, Inc.. (11/14/24). "Press Release: Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction". San Diego, CA. |
2024-11-14 |
BioNTech SE. (11/13/24). "Press Release: BioNTech to Acquire Biotheus to Boost Oncology Strategy". Mainz. |
2024-11-13 |
Centogene N.V.. (11/13/24). "Press Release: Centogene Signs Strategic Transaction with Private Equity Group Charme Capital Partners [not for release, publication or distribution, where unlawful]". Cambridge, MA & Rostock. |
2024-11-13 |
High-Tech Gründerfonds Management GmbH. (11/12/24). "Press Release: Zymofix Secures €2 Million to Scale Microbial Solutions for Sustainable Agriculture and Beyond". Ghent. |
2024-11-12 |
Alentis Therapeutics AG. (11/12/24). "Press Release: Alentis Therapeutics Raises $181.4 Million in an Oversubscribed Series D Financing to Advance the Clinical Development of Anti-Claudin-1 ADCs in Solid Tumors". Basel. |
2024-11-12 |
Mediaire GmbH. (11/12/24). "Press Release: Mediaire Transforms Radiology with AI, Securing a European €12 Million Investment to Fuel Global Growth". |
2024-11-12 |
PrognomiQ. (11/5/24). "Press Release: PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform". San Mateo, CA. |
2024-11-05 |
High-Tech Gründerfonds Management GmbH. (10/31/24). "Press Release: Berlin-Based Neurotech Startup Nuuron Secures Investment for the Development of a Digital Drug to Treat Alzheimer’s Disease". |
2024-10-31 |
Kynos Therapeutics Ltd.. (10/29/24). "Press Release: Dr. Falk Pharma Acquires Kynos Therapeutics, Adding Acute Pancreatitis as a Therapeutic Focus and Further Strengthening Its Development Portfolio". Freiburg. |
2024-10-29 |
Inbrain Neuroelectronics S.L.. (10/29/24). "Press Release: Inbrain Neuroelectronics Raises $50M Series B to Advance Graphene-Based Brain-Computer Interface Technology". Barcelona. |
2024-10-29 |
Aignostics GmbH. (10/29/24). "Press Release: Aignostics Secures $34M Series B to Enhance Precision Medicine with AI". Berlin & New York, NY. |
2024-10-29 |
Ottimo Pharma Ltd.. (10/28/24). "Press Release: Ottimo Pharma Emerges from Stealth with Backing from Medicxi and Management Team Led by David Epstein to Accelerate Development of a Novel PD1/VEGFR2 Bi-Functional Antibody Planned to Enter the Clinic in 20 |
2024-10-28 |
Kivu Bioscience. (10/28/24). "Kivu Bioscience Raises $92 Million Series A Led by Novo Holdings to Advance Next-Generation Antibody-Drug Conjugates". San Francisco, CA. |
2024-10-28 |
ICR Inc.. (10/22/24). "Press Release: ICR Healthcare Launches as a Unified Global Brand in Healthcare Strategic Communications and Investor Relations". New York, NY & London. |
2024-10-22 |
UpNano GmbH. (10/17/24). "Press Release: Industry Groups Invest in High Performance 2PP 3D Print Technology". Vienna. |
2024-10-17 |
Nuclera Ltd.. (10/16/24). "Press Release: Nuclera Closes $75 Million USD Financing
> Series C round led by Elevage Medical Technologies". Cambridge & Boston, MA. |
2024-10-16 |
Invios GmbH. (10/15/24). "Press Release: Invios Raises €8.2 Million in a Series A to Finance Pipeline Progress in Immuno-oncology". Vienna. |
2024-10-15 |
Antiverse Ltd.. (10/15/24). "Press Release: Antiverse Raises £3.5M ($4.6M) to Advance Generative AI Antibody Design Platform". Cardiff. |
2024-10-15 |
Shift Bioscience Ltd.. (10/15/24). "Press Release: Shift Bioscience Raises $16M to Advance Cell Simulation AI Platform". Cambridge. |
2024-10-15 |
H. Lundbeck A/S. (10/14/24). "Press Release: Lundbeck to Acquire Longboard Pharmaceuticals in a Strategic Deal, Significantly Enhancing Its Neuroscience Pipeline". Valby & La Jolla, CA. |
2024-10-14 |
Booster Therapeutics GmbH. (10/10/24). "Press Release: Booster Therapeutics Launches to Pioneer New Class of Proteasome Activator Medicines for the Treatment of a Range of Complex Diseases". Berlin. |
2024-10-10 |
Lumicks Technologies B.V.. (10/10/24). "Press Release: Dutch Life Science Tools [Company] Lumicks Secures €20 Million from European Investment Bank to Accelerate Drug Discovery for Cancer". |
2024-10-10 |
Immatics N.V.. (10/10/24). "Press Release: Immatics Announces Proposed $150 Million Public Offering". Houston, TX & Tübingen. |
2024-10-10 |
Clock Bio Ltd.. (10/9/24). "Press Release: clock.bio Raises $5.3M Seed Funding and Decodes Genetic Atlas of Human Rejuvenation Factors". Cambridge. |
2024-10-09 |
a:head bio AG. (10/9/24). "Press Release: a:head Secures Pre-Series A Funding and Appoints Margarete Schramboeck and Madeline Lancaster to the Supervisory Board". Vienna. |
2024-10-09 |
Purespring Therapeutics Ltd.. (10/9/24). "Press Release: Purespring Therapeutics Raises £80/$105 Million in a Series B Financing to Transform the Treatment of Kidney Diseases". London. |
2024-10-09 |
Lymphatica Medtech S.A.. (10/8/24). "Press Release: Lymphatica Medtech Closes €17.9m Series B Funding Round to Drive Innovation in Lymphedema Treatment". Lausanne. |
2024-10-08 |
Somagenetix AG. (10/8/24). "Press Release: Somagenetix AG Secures CHF 10 Million in Series A Financing to Advance Lentiviral Gene Therapy for Chronic Granulomatous Disease (CGD)". Zurich. |
2024-10-08 |
Mérieux NutriSciences Corporation. (10/7/24). "Press Release: Mérieux NutriSciences Enters Agreement to Acquire Worldwide Food Testing Business of Bureau Veritas". Chicago, IL. |
2024-10-07 |
Kurma Partners. (10/3/24). "Press Release: Kurma Partners Achieves First Close of New EUR 250 Million Biofund IV". Paris. |
2024-10-03 |
Enara Bio Ltd.. (10/3/24). "Press Release: Enara Bio Raises $32.5 Million Series B Financing to Advance First-in-Class Pipeline of TCR-based Immunotherapies Targeting Novel Dark Antigens". Oxford. |
2024-10-03 |
LoQus23 Therapeutics Ltd.. (10/2/24). "Press Release: LoQus23 Therapeutics Announces £35 Million (c.$43 Million) Series A Financing to Advance Its Small Molecule Somatic Expansion Inhibition Therapy for Huntington’s Disease". Cambridge. |
2024-10-02 |
Bruker Corporation. (10/2/24). "Press Release: Bruker Acquires Dynamic Biosensors, a Pioneer of Single-Cell Interaction Cytometry Systems for Drug Discovery". Munich. |
2024-10-02 |
Aitiologic GmbH. (10/1/24). "Press Release: Aitiologic Emerges from Stealth Mode with over €2.5M in Funding to Advance AI-powered Liquid Biopsy Platform for Early Disease Detection". Vienna. |
2024-10-01 |
1BillionLives GmbH (d/b/a Flinn). (9/30/24). "Press Release: Flinn.ai Secures 10 Million Euros in Less than 18 Months". |
2024-09-30 |
Sequentia Biotech S.L.. (9/27/24). "Press Release: Sequentia Biotech Secures €10 Million Equity Investment from Seventure Partners and the EIC Fund to Boost Bioinformatic Solutions for Clinical, Industrial and Research Applications". Barcelona. |
2024-09-27 |
Genespire S.r.l.. (9/25/24). "Press Release: Genespire Raises €46.6 Million (~$52 Million) in a Series B Round to Advance Its First Pediatric in-vivo Gene Therapy into the Clinic". Milan. |
2024-09-25 |
Minaris Regnerative Medicine GmbH. (9/24/24). "Press Release: Minaris Regenerative Medicine Announces Agreement to be Acquired by Altaris". Yokohama, Munich & Allendale, NJ. |
2024-09-24 |
Resonac Corporation. (9/24/24). "Press Release: Resonac Corporation Signs Contract to Transfer Shares of Minaris Regenerative Medicine Subsidiaries to Altaris". Zwingenberg. |
2024-09-24 |
Lift BioSciences Ltd.. (9/24/24). "Press Release: Lift BioSciences Raises £10m in First Close of Series A to Advance First-in-Class Allogeneic Innate Cell Therapy". Milan. |
2024-09-24 |
Noah Labs GmbH. (9/19/24). "Press Release: Noah Labs Receives €3 Million in Financing Round Led by Nina Capital". Berlin & Potsdam. |
2024-09-19 |
Organon & Co.. (9/18/24). "Press Release: Organon to Acquire Dermavant including Its Innovative Dermatologic Therapy, Vtama (tapinarof) Cream, 1%". Jersey City, NJ. |
2024-09-18 |
Boehringer Ingelheim Stiftung / ÖAW. (9/18/24). "Press Release: OeAW and Boehringer Ingelheim Foundation Establish New Institute for Biomedical Artificial Intelligence in Vienna". Mainz. |
2024-09-18 |
Subject Well, Inc. (SubjectWell). (9/17/24). "Press Release: SubjectWell Announces Strategic Acquisition of Trials24 to Expand Global Patient Recruitment Capabilities". |
2024-09-17 |
ImmunOs Therapeutics AG. (9/17/24). "Press Release: ImmunOs Therapeutics AG Raises $11 Million and Further Strengthens Investor Base". |
2024-09-17 |
High-Tech Gründerfonds Management GmbH. (9/16/24). "Press Release: Symphera Secures €2.4 Million in Seed Financing to Revolutionize Laparoscopic Surgery". Munich. |
2024-09-16 |
Inflammatix, Inc.. (9/12/24). "Press Release: Inflammatix Secures $57 Million to Advance Novel Diagnostic for Patients with Suspected Infections or Sepsis". Sunnyvale, CA. |
2024-09-12 |
Abolis Biotechnologies SAS. (9/12/24). "Press Release: Abolis Biotechnologies Secures 35 Mio. Euro from International Consortium of Industrials and Funds". Èvry-Courcouronnes. |
2024-09-12 |
CPTx GmbH. (9/12/24). "Press Release: CPTx Secures $29 Million to Advance Breakthrough Antiviral Platform". Planegg. |
2024-09-12 |
Novameat Tech SL. (9/12/24). "Press Release: Novameat Raises €17.4M Oversubscribed Series A Round Led by Sofinnova Partners and Forbion". Barcelona. |
2024-09-12 |
Ion Beam Applications S.A. (IBA). (9/11/24). "Press Release: IBA’s Joint Venture PanTera Secures EUR 93 Million in Oversubscribed Series A Round to Accelerate Global Actinium-225 Production". Louvain-la-Neuve. |
2024-09-11 |
Forbion Capital Partners. (9/11/24). "Press Release: Forbion Leads $14m Series A in Solasta Bio to Advance Development and Commercialisation of First-in-class Sustainable Crop Protection Solutions". Naarden. |
2024-09-11 |
Formo Bio GmbH. (9/10/24). "Press Release: Formo Bags $61 Million in Series B Funding – Launches the World’s First Animal-free Cheese Made with Koji Protein". |
2024-09-10 |
Agronomics Ltd.. (9/10/24). "Press Release: Formo Closes a US$ 61 Million Series B Round". |
2024-09-10 |
PhoreMost Ltd.. (9/10/24). "Press Release: PhoreMost Extends Series B Financing to $50M to Advance High-value Oncology and Inflammation Degrader Programmes". Cambridge. |
2024-09-10 |
NanoSyrinx Ltd.. (9/10/24). "Press Release: NanoSyrinx Closes £10 Million GBP Financing and Appoints Dr. Edwin Moses as Chairman". Coventry. |
2024-09-10 |
Epsilogen Ltd.. (9/9/24). "Press Release: Epsilogen Completes £12.5 Million Series B Financing Expansion". London. |
2024-09-09 |
eGenesis Inc.. (9/4/24). "Press Release: eGenesis Raises $191 Million Series D Financing to Advance Lead Program for Kidney Transplant". Cambridge, MA. |
2024-09-04 |
Qiagen N.V.. (9/3/24). "Press Release: Qiagen N.V. Announces Successful Placement of New Net Share Settled Convertible Bonds [not for US, CA, AU, JP, ZA, et al.]". Venlo. |
2024-09-03 |
Boehringer Ingelheim. (9/3/24). "Press Release: Boehringer Ingelheim Acquires Saiba Animal Health, Adding Innovative Technology Platform to Its Pet Therapeutics R&D Portfolio". Ingelheim. |
2024-09-03 |